IMPORTANT: Beginning at 8:00 AM on July 22, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.

800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial (NAIL-IT)

view all Clinical Trials

Overview

Evaluation of safety and thrombolytic effect of ascending doses of TS23 in subjects with intermediate-risk (sub-massive) acute pulmonary embolism (PE).

Clinical Trial Information

Protocol

TIRB# 30780

Phase

2

Condition(s)

Pulmonary Embolism, Pulmonary Vascular Disease

Investigator

Parth Rali, MD

Coordinator

Kim Selwood

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

Evaluation of the Safety and Thrombolytic Effects of Ascending Doses of TS23 in Subjects With Intermediate-Risk (Sub-Massive) Acute Pulmonary Embolism

Related Clinical Trials

A Study of Mosliciguat in PH-ILD (PHocus)

TIRB#: 32203
  • Conditions: Interstitial Lung Disease (ILD), Pulmonary Hypertension (PH), Pulmonary Vascular Disease
  • Investigator: Parth Rali, MD
  • Coordinator: Kim Selwood
View Details

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

TIRB#: 32025
  • Conditions: Interstitial Lung Disease (ILD), Pulmonary Fibrosis (Including IPF)
  • Investigator: Parth Rali, MD
  • Coordinator: Kim Selwood
View Details